CYTOKINETICS INC 4

Director James M. Daly received an equity retainer grant of 151 shares of Cytokinetics Inc. common stock in lieu of cash fees.

On July 15, 2026, reporting person James M. Daly, a director of Cytokinetics Inc., received a fully vested grant of 151 shares of common stock under the company’s Equity in lieu of Cash Retainer Program, effectively taking equity instead of cash fees. The shares were valued at approximately $82.62 per share, implying an aggregate grant value of about $12,472, and brought his direct ownership to 3,390 shares following the transaction.

Filing Facts

CIK

1061983

Ticker

CYTK

Form

4

Source Type

fda

Accession

0001061983-26-000078

Alert Tier

4